News

Unlike the brain and spinal cord, peripheral nerve cells, whose long extensions reach the skin and internal organs, are ...
To build proteins, cells rely on a molecule called transfer RNA, or tRNA. tRNAs act like protein-building couriers, where ...
Researchers have described proteins that they say are among the most ancient ever sequenced. Two teams, which analysed ...
To build proteins, cells rely on a molecule called transfer RNA, or tRNA. tRNAs act like protein-building couriers, where ...
No longer a mere assistant who carries out the commands of DNA, RNA takes the lead in emerging therapeutics.
To build proteins, cells rely on a molecule called transfer RNA, or tRNA. tRNAs act like protein-building couriers, where ...
Professor Hirohide Saito and his research team have developed a new microRNA-responsive hybrid mRNA switch, enabling precise, ...
Everest Medicines unveils breakthroughs in AI+mRNA platform, reinforces global leadership in next-gen mRNA innovation: Hong Kong Monday, July 7, 2025, 10:00 Hrs [IST] Everest Medi ...
Everest Medicines (HKEX: 1952.HK), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative medicines, recently hosted the "2025 ...
The Hong Kong-listed firm is advancing its pipeline using an mRNA system it says can compete with the industry’s best.
Assessing the distribution of a medication in the brain is critical for the treatment of a vast range of neurological ...
Global Antisense and RNAi therapeutics Market is valued approximately at USD 3.69 billion in 2022 and is anticipated to grow with a healthy growth rate of more than 18.72% over the forecast period ...